source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[disease]	characteristics[biological replicate]	assay name	Technology type	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[fractionation method]	comment[label]	comment[technical replicate]	comment[cleavage agent details]	comment[MS2 mass analyzer]	comment[instrument]	comment[separation]	comment[modification parameter 1]	comment[modification parameter 2]	comment[modification parameter 3]	comment[modification parameter 4]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[organism part]	factor value[phenotype]
PXD040438-Sample-1	Homo sapiens	blood plasma	not applicable	COVID-19	1	03COVID	proteomic profiling by mass spectrometry	03COVID.raw	/app/raw/03COVID.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251	AC=MS:1003029; NT=Orbitrap Eclipse	AC=MS:1000073; NT=Electrospray ionization	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Met-loss;AC=UNIMOD:765;MT=Variable;TA=M	NT=Met-loss+Acetyl;AC=UNIMOD:766;MT=Variable;TA=M	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	30 NCE	20 ppm	0.6 Da	blood plasma	control
PXD040438-Sample-2	Homo sapiens	blood plasma	not applicable	COVID-19	1	02COVID	proteomic profiling by mass spectrometry	02COVID.raw	/app/raw/02COVID.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251	AC=MS:1003029; NT=Orbitrap Eclipse	AC=MS:1000073; NT=Electrospray ionization	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Met-loss;AC=UNIMOD:765;MT=Variable;TA=M	NT=Met-loss+Acetyl;AC=UNIMOD:766;MT=Variable;TA=M	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	30 NCE	20 ppm	0.6 Da	blood plasma	control
PXD040438-Sample-3	Homo sapiens	blood plasma	not applicable	COVID-19	1	07COVID	proteomic profiling by mass spectrometry	07COVID.raw	/app/raw/07COVID.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251	AC=MS:1003029; NT=Orbitrap Eclipse	AC=MS:1000073; NT=Electrospray ionization	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Met-loss;AC=UNIMOD:765;MT=Variable;TA=M	NT=Met-loss+Acetyl;AC=UNIMOD:766;MT=Variable;TA=M	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	30 NCE	20 ppm	0.6 Da	blood plasma	control
PXD040438-Sample-4	Homo sapiens	blood plasma	not applicable	COVID-19	1	09COVID	proteomic profiling by mass spectrometry	09COVID.raw	/app/raw/09COVID.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251	AC=MS:1003029; NT=Orbitrap Eclipse	AC=MS:1000073; NT=Electrospray ionization	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Met-loss;AC=UNIMOD:765;MT=Variable;TA=M	NT=Met-loss+Acetyl;AC=UNIMOD:766;MT=Variable;TA=M	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	30 NCE	20 ppm	0.6 Da	blood plasma	case
PXD040438-Sample-5	Homo sapiens	blood plasma	not applicable	COVID-19	1	11COVID	proteomic profiling by mass spectrometry	11COVID.raw	/app/raw/11COVID.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251	AC=MS:1003029; NT=Orbitrap Eclipse	AC=MS:1000073; NT=Electrospray ionization	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Met-loss;AC=UNIMOD:765;MT=Variable;TA=M	NT=Met-loss+Acetyl;AC=UNIMOD:766;MT=Variable;TA=M	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	30 NCE	20 ppm	0.6 Da	blood plasma	case
PXD040438-Sample-6	Homo sapiens	blood plasma	not applicable	COVID-19	1	15COVID	proteomic profiling by mass spectrometry	15COVID.raw	/app/raw/15COVID.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251	AC=MS:1003029; NT=Orbitrap Eclipse	AC=MS:1000073; NT=Electrospray ionization	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Met-loss;AC=UNIMOD:765;MT=Variable;TA=M	NT=Met-loss+Acetyl;AC=UNIMOD:766;MT=Variable;TA=M	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	30 NCE	20 ppm	0.6 Da	blood plasma	case